HOME Top Market Reports Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape & Forecast to 2017

Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape & Forecast to 2017

By: marketsandmarkets.com
Publishing Date: July 2012
Report Code: MD 1181

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


Sleep problems are touted as a ‘global epidemic’ and sleep apnea is a crucial contributor to this disorder. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea; around 84% of people with sleep apnea are diagnosed with the disease. Studies suggest that about 100 million people worldwide are suspected to have obstructive sleep apnea, of which more than 80% remain undiagnosed.

The global sleep apnea devices market is broadly segmented into two categories, namely, Diagnostic Devices and Therapeutic Devices. The industry is technology driven and technological advancements in both diagnostic and therapeutic devices such as PSG devices, screening devices, actigraphy systems, Positive Airway Pressure (PAP) devices, humidifiers, adaptive servo-ventilation systems, oxygen devices, oral appliances, and accessories have enhanced patient compliance levels in recent years.

Incessantly rising obesity and incidence of sleep apnea, increasing awareness regarding hypertension, stroke, Type II diabetes/adult onset diabetes and cardiovascular diseases and its association with sleep apnea, increased adoption and acceptance of home sleep testing devices, growing preference for oral appliances, technological advancement in diagnostic/therapeutic devices, and upcoming novel therapies are the major drivers that are slated to propel this market, while limited reimbursement, coupled with lack of patient compliance is a pivotal factor restraining the growth of this market. The market is dominated by global players like Philips Respironics, ResMed, Inc., Natus Medical Incorporated, Fisher and Paykel Healthcare, Compumedics Limited, and CareFusion Corporation, among others.

The sleep apnea devices segments will grow at a CAGR of 15% and 17%, respectively, by 2017. The diagnostic devices market is propelled by PSG devices, particularly clinical PSG devices. The usage of Ambulatory PSG devices is slated to increase in the next few years due to observed patient preference to be tested at home for convenience reasons, patient’s inclination to skip the unfamiliar environment of sleep labs, and cost–effectiveness of these devices. The global demand for other diagnostic devices such as respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems is also on the rise due to their low costs. These devices serve as cost-effective and convenient options, as compared to PSG devices, especially for the low-economic class patient pool. 

The therapeutic devices market is predominantly driven by PAP devices, as these are considered to be the first line treatment for sleep apnea and hence are most prescribed by sleep specialists. Insurance cover for PAP devices and other supplies in developed geographies like the U.S. and select countries in Europe is expected to boost sleep apnea devices market demand. However, non- compliance issue with PAP devices is expected to boost the growth of the oral appliances market. The accessories market was the largest in 2011, in terms of volume, as they are an integral component of sleep apnea diagnostic and therapeutic devices. With a growing sleep apnea patient pool, the demand for sleep apnea diagnostic/therapeutic devices and accessories is bound to grow.

The global sleep apnea devices market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the sleep apnea device market in the years to come, followed by Europe. As reimbursement policies become more consistent across European countries, sustained steady growth is expected from the region in the coming years. The Asian region’s contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition from both patients and the medical fraternity alike.

Scope of the Report

The sleep apnea devices market research report categorizes the global market into Diagnostic Devices and Therapeutic Devices. Both of these markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for 2009, 2010 and 2011, as well as forecast up to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. A separate segment of end-user analysis is also incorporated in the report to provide information on devices that are used exclusively at hospital or at home and devices that are used at both places.

Global Sleep Apnea Devices Market, by segments

  • Diagnostic Devices
  • Therapeutic Devices

Global Sleep Apnea Devices Market, by products

  • Polysomnography (PSG) Devices    
    • Clinical PSG Devices 
    • Ambulatory PSG Devices     
  • Respiratory polygraphs       
  • Two Channel Screening Devices (Nasal Flow Sensors, SPO2)      
  • Single Channel Screening Devices (Pulse Oximeters)       
  • Actigraphy Systems 

Global Sleep Apnea Devices Market, by products

  • Positive Airway Pressure (PAP) Devices
    • CPAP Devices
    • APAP Devices
    • Bi-level Devices
  • Facial Interfaces
    • Masks
      • Full Face Masks
      • Nasal Masks
      • Nasal Pillow Masks
      • Oral Masks
  • Adaptive Servo-Ventilation
  • Airway Clearance Systems
  • Oxygen Devices
    • Concentrators
    • Home Oxygen Filling Systems
    • Liquid Portable Oxygen
  • Accessories
    • Pillows
    • Masks Cleaning Wipes
    • Chin Restraints
    • Tube Covers
    • Filters
    • DC Convertors
    • Power & Batteries
    • Headgears
    • Nebulizers
    • Tubings
    • Humidifiers
    • Others
  • Oral Appliances
    • Mandibular Advancement Device (MAD)
    • Tongue Retaining Device (TRD)
    • Others
  • Novel therapies

Global Sleep Apnea Devices Market, by end-users

  • Home Devices
  • Hospital Devices
  • Both (Home and Hospital) Devices

Sleep Apnea Devices Market, by geography

  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)

TABLE OF CONTENTS
 
1 INTRODUCTION 

  1.1 KEY TAKE-AWAYS 
  1.2 REPORT DESCRIPTION 
  1.3 MARKETS COVERED 
  1.4 STAKEHOLDERS 
  1.5 RESEARCH METHODOLOGY 
      1.5.1 MARKET SIZE 
      1.5.2 MARKET SHARE 
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES 
      1.5.5 ASSUMPTIONS 
  
2 EXECUTIVE SUMMARY 
  
3 MARKET OVERVIEW 

  3.1 INTRODUCTION 
      3.1.1 STAGES OF SLEEP 
            3.1.1.1 Sleep Cycle 
      3.1.2 SLEEP DISORDERS 
      3.1.3 SLEEP APNEA 
      3.1.4 ANATOMY OF SLEEP APNEA EPISODE 
      3.1.5 CLASSIFICATION OF SLEEP APNEA 
      3.1.6 CAUSES 
            3.1.6.1 Central sleep apnea (CSA) 
            3.1.6.2 Obstructive sleep apnea (OSA) 
      3.1.7 SIGNS & SYMPTOMS 
            3.1.7.1 Central sleep apnea 
            3.1.7.2 Obstructive sleep apnea 
            3.1.7.3 Signs and symptoms in children 
      3.1.8 RISK FACTORS 
            3.1.8.1 Central sleep apnea 
            3.1.8.2 Obstructive Sleep Apnea 
      3.1.9 DIAGNOSIS 
            3.1.9.1 Sleep apnea diagnosis & sleep recording test 
      3.1.10 TREATMENT OPTIONS 
      3.1.11 CO-MORBID CONDITIONS 
  3.2 MARKET DYNAMICS 
      3.2.1 PORTER'S FIVE FORCES ANALYSIS 
            3.2.1.1 Threat of new entrants 
            3.2.1.2 Supplier's bargaining power 
            3.2.1.3 Buyer's bargaining power 
            3.2.1.4 Segment rivalry 
            3.2.1.5 Threat of substitutes 
      3.2.2 DRIVERS 
            3.2.2.1 Colossal pool of sleep apnea patients 
            3.2.2.2 Increasing awareness 
            3.2.2.3 Growing usage of oral appliances 
            3.2.2.4 Technological advancements 
      3.2.3 RESTRAINTS 
            3.2.3.1 Reimbursement concerns 
            3.2.3.2 Lack of patient compliance 
      3.2.4 MARKET SHARE, BY KEY PLAYERS 
  
4 GLOBAL SLEEP APNEA DEVICES MARKET, BY SEGMENTS 
  4.1 INTRODUCTION 
  
5 GLOBAL SLEEP APNEA DEVICES MARKET, BY PRODUCTS 
  5.1 INTRODUCTION 
  5.2 POLYSOMNOGRAPHY (PSG) DEVICE 
      5.2.1 CLINICAL PSG DEVICE 
      5.2.2 AMBULATORY PSG DEVICE 
  5.3 RESPIRATORY POLYGRAPH 
  5.4 TWO CHANNEL SCREENING DEVICES (NASAL FLOW SENSORS, SPO2) 
  5.5 SINGLE CHANNEL SCREENING DEVICES (PULSE OXIMETERS) 
      5.5.1 HAND-HELD PULSE OXIMETERS 
      5.5.2 FINGERTIP PULSE OXIMETERS 
      5.5.3 TABLE-TOP PULSE OXIMETERS 
      5.5.4 WRIST-WORN PULSE OXIMETERS 
  5.6 ACTIGRAPHY SYSTEMS 
  
6 GLOBAL SLEEP APNEA DEVICES MARKET, BY PRODUCTS 
  6.1 INTRODUCTION 
  6.2 POSITIVE AIRWAY PRESSURE (PAP) DEVICE 
      6.2.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICE 
      6.2.2 AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICE 
      6.2.3 BILEVEL (BPAP) DEVICE 
  6.3 FACIAL INTERFACES 
      6.3.1 MASKS 
            6.3.1.1 Full face masks 
            6.3.1.2 Nasal masks 
            6.3.1.3 Nasal pillow masks 
            6.3.1.4 Oral masks 
  6.4 ADAPTIVE SERVO-VENTILATION (ASV) 
  6.5 AIRWAY CLEARANCE SYSTEMS 
  6.6 OXYGEN DEVICES 
      6.6.1 CONCENTRATORS 
      6.6.2 HOME OXYGEN FILLING SYSTEMS 
      6.6.3 LIQUID PORTABLE OXYGEN 
  6.7 ACCESSORIES 
      6.7.1 PILLOWS 
      6.7.2 MASKS CLEANING WIPES 
      6.7.3 CHIN RESTRAINTS 
      6.7.4 TUBE COVERS 
      6.7.5 FILTERS 
      6.7.6 DC CONVERTORS 
      6.7.7 POWER & BATTERIES 
      6.7.8 HEADGEAR 
      6.7.9 NEBULIZERS 
      6.7.10 TUBINGS 
      6.7.11 HUMIDIFIERS 
      6.7.12 OTHERS 
  6.8 ORAL APPLIANCES 
      6.8.1 MANDIBULAR ADVANCEMENT DEVICE (MAD) 
      6.8.2 TONGUE RETAINING DEVICE (TRD) 
      6.8.3 OTHERS 
            6.8.3.1 Boil and bite appliances 
            6.8.3.2 Laboratory - fabricated appliances 
                    6.8.3.2.1 Klearway appliance 
                    6.8.3.2.2 Thornton adjustable positioners (TAP) 
                    6.8.3.2.3 Herbst appliance 
            6.8.3.3 Nocturnal airway patency appliance (NAPA) 
            6.8.3.4 Oral pressure appliance (OPAP) 
  6.9 NOVEL THERAPIES 
      6.9.1 NEUROSTIMULATION 
            6.9.1.1 Upper airway stimulation therapy by Inspire Medical Systems 
            6.9.1.2 Hypoglossal nerve stimulation system by Apnex Medical, Inc. 
            6.9.1.3 Targeted hypoglossal neurostimulation (THN) sleep therapy by Imthera Medical 
      6.9.2 SLEEP POSITION TRAINER, BY NIGHTBALANCE 
      6.9.3 PROVENT THERAPY, BY VENTUS MEDICAL 
      6.9.4 WINX SLEEP THERAPY SYSTEM, BY APNICURE 
  
7 GLOBAL SLEEP APNEA DEVICES MARKET, BY END-USERS 
  7.1 INTRODUCTION 
  
8 GEOGRAPHIC ANALYSIS 
  8.1 INTRODUCTION 
  8.2 NORTH AMERICA 
  8.3 EUROPE 
  8.4 ASIA 
  8.5 REST OF THE WORLD (ROW) 
  
9 COMPETITIVE LANDSCAPE 
  9.1 INTRODUCTION 
  9.2 NEW PRODUCTS DEVELOPMENTS 
  9.3 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/JOINT VENTURES  
  9.4 MERGERS & ACQUISITIONS 
  9.5 OTHERS 
  
10 COMPANY PROFILES 
   10.1 APNEX MEDICAL, INC. 
        10.1.1 OVERVIEW 
        10.1.2 FINANCIALS 
        10.1.3 PRODUCTS & SERVICES 
        10.1.4 STRATEGY 
        10.1.5 DEVELOPMENTS 
   10.2 BMC MEDICAL CO., LTD. 
        10.2.1 OVERVIEW 
        10.2.2 FINANCIALS 
        10.2.3 PRODUCTS & SERVICES 
        10.2.4 STRATEGY 
        10.2.5 DEVELOPMENTS 
   10.3 BRAEBON MEDICAL CORPORATION 
        10.3.1 OVERVIEW 
        10.3.2 FINANCIALS 
        10.3.3 PRODUCTS & SERVICES 
        10.3.4 STRATEGY 
        10.3.5 DEVELOPMENTS 
   10.4 CADWELL LABORATORIES, INC. 
        10.4.1 OVERVIEW 
        10.4.2 FINANCIALS 
        10.4.3 PRODUCTS & SERVICES 
        10.4.4 STRATEGY 
        10.4.5 DEVELOPMENTS 
   10.5 CAREFUSION CORPORATION 
        10.5.1 OVERVIEW 
        10.5.2 FINANCIALS 
        10.5.3 PRODUCTS & SERVICES 
        10.5.4 STRATEGY 
        10.5.5 DEVELOPMENTS 
   10.6 COMPUMEDICS LIMITED 
        10.6.1 OVERVIEW 
        10.6.2 FINANCIALS 
        10.6.3 PRODUCTS 
        10.6.4 STRATEGY 
        10.6.5 DEVELOPMENTS 
   10.7 CURATIVE MEDICAL, INC. 
        10.7.1 OVERVIEW 
        10.7.2 FINANCIALS 
        10.7.3 PRODUCTS & SERVICES 
        10.7.4 STRATEGY 
        10.7.5 DEVELOPMENTS 
   10.8 FISHER AND PAYKEL HEALTHCARE, LTD. 
        10.8.1 OVERVIEW 
        10.8.2 FINANCIALS 
        10.8.3 PRODUCTS & SERVICES 
        10.8.4 STRATEGY 
        10.8.5 DEVELOPMENTS 
   10.9 GE HEALTHCARE 
        10.9.1 OVERVIEW 
        10.9.2 FINANCIALS 
        10.9.3 PRODUCTS & SERVICES 
        10.9.4 STRATEGY 
        10.9.5 DEVELOPMENTS 
   10.10 GLOBAL MEDICAL HOLDINGS, LLC 
         10.10.1 OVERVIEW 
         10.10.2 FINANCIALS 
         10.10.3 PRODUCTS 
         10.10.4 STRATEGY 
         10.10.5 DEVELOPMENTS 
   10.11 IMTHERA MEDICAL, INC. 
         10.11.1 OVERVIEW 
         10.11.2 FINANCIALS 
         10.11.3 PRODUCTS 
         10.11.4 STRATEGY 
         10.11.5 DEVELOPMENTS 
   10.12 INVACARE CORPORATION 
         10.12.1 OVERVIEW 
         10.12.2 FINANCIALS 
         10.12.3 PRODUCT & SERVICES 
         10.12.4 STRATEGY 
         10.12.5 DEVELOPMENTS 
   10.13 ITAMAR MEDICAL, LTD. 
         10.13.1 OVERVIEW 
         10.13.2 FINANCIALS 
         10.13.3 PRODUCTS & SERVICES 
         10.13.4 STRATEGY 
         10.13.5 DEVELOPMENTS 
   10.14 NATUS MEDICAL, INC. 
         10.14.1 OVERVIEW 
         10.14.2 FINANCIALS 
         10.14.3 PRODUCTS & SERVICES 
         10.14.4 STRATEGY 
         10.14.5 DEVELOPMENTS 
   10.15 NIHON KOHDEN 
         10.15.1 OVERVIEW 
         10.15.2 FINANCIALS 
         10.15.3 PRODUCTS & SERVICES 
         10.15.4 STRATEGY 
         10.15.5 DEVELOPMENTS 
   10.16 PHILIPS HEALTHCARE 
         10.16.1 OVERVIEW 
         10.16.2 FINANCIALS 
         10.16.3 PRODUCTS & SERVICES 
         10.16.4 STRATEGY 
         10.16.5 DEVELOPMENTS 
   10.17 RESMED, INC. 
         10.17.1 OVERVIEW 
         10.17.2 FINANCIALS 
         10.17.3 PRODUCTS & SERVICES 
         10.17.4 STRATEGY 
         10.17.5 DEVELOPMENTS 
   10.18 SOMNETICS INTERNATIONAL, INC. 
         10.18.1 OVERVIEW 
         10.18.2 FINANCIALS 
         10.18.3 PRODUCTS 
         10.18.4 STRATEGY 
         10.18.5 DEVELOPMENTS 
   10.19 SOMNOMEDICS GMBH 
         10.19.1 OVERVIEW 
         10.19.2 FINANCIALS 
         10.19.3 PRODUCTS & SERVICES 
         10.19.4 STRATEGY 
         10.19.5 DEVELOPMENTS 
   10.20 TELEFLEX, INC. 
         10.20.1 OVERVIEW 
         10.20.2 FINANCIALS 
         10.20.3 PRODUCTS & SERVICES 
         10.20.4 STRATEGY 
         10.20.5 DEVELOPMENTS 
   10.21 VENTUS MEDICAL, INC. 
         10.21.1 OVERVIEW 
         10.21.2 FINANCIALS 
         10.21.3 PRODUCTS 
         10.21.4 STRATEGY 
         10.21.5 DEVELOPMENTS 
   10.22 WEINMANN MEDICAL DEVICES GMBH & CO. KG 
         10.22.1 OVERVIEW 
         10.22.2 FINANCIALS 
         10.22.3 PRODUCTS & SERVICES 
         10.22.4 STRATEGY 
         10.22.5 DEVELOPMENTS 


LIST OF TABLES 
  
TABLE 1 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2017 ($BILLION)  
TABLE 2  GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 3  GLOBAL SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 4  GLOBAL PSG DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)   
TABLE 5  GLOBAL PSG DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)   
TABLE 6  CLINICAL PSG DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 7  CLINICAL PSG DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 8  AMBULATORY PSG DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 9  AMBULATORY PSG DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 10 RESPIRATORY POLYGRAPH MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 11 RESPIRATORY POLYGRAPH MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 12 TWO CHANNEL SCREENING DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 13 TWO CHANNEL SCREENING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)  
TABLE 14 GLOBAL SINGLE CHANNEL SCREENING DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)   
TABLE 15 GLOBAL SINGLE CHANNEL SCREENING DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)   
TABLE 16 HAND-HELD PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 17 HAND-HELD PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 18 FINGERTIP PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 19 FINGERTIP PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 20 TABLE-TOP PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 21 TABLE-TOP PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 22 WRIST-WORN PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 23 WRIST-WORN PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)  
TABLE 24 ACTIGRAPHY SYSTEM MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 25 ACTIGRAPHY SYSTEM MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 26 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 27 GLOBAL SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 28 GLOBAL PAP DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)   
TABLE 29 GLOBAL PAP DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)  
TABLE 30 CPAP DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 31 CPAP DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 32 APAP DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 33 APAP DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 34 BILEVEL DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 35 BILEVEL DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 36 GLOBAL MASKS MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)  
TABLE 37 GLOBAL MASKS MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)   
TABLE 38 FULL FACE MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 39 FULL FACE MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 40 NASAL MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 41 NASAL MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 42 NASAL PILLOW MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 43 NASAL PILLOW MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)    TABLE 44 ORAL MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 45 ORAL MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 46 ADAPTIVE SERVO-VENTILATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 47 ADAPTIVE SERVO-VENTILATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)  
TABLE 48 AIRWAY CLEARANCE SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 49 AIRWAY CLEARANCE SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 50 GLOBAL OXYGEN DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 51 GLOBAL OXYGEN DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 52 CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 53 CONCENTRATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 54 HOME OXYGEN FILLING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 55 HOME OXYGEN FILLING SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)  
TABLE 56 LIQUID PORTABLE OXYGEN MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 57 LIQUID PORTABLE OXYGEN MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 58 GLOBAL ACCESSORIES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 59 GLOBAL ACCESSORIES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 60 PILLOWS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 61 PILLOWS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 62 MASKS CLEANING WIPES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 63 MASKS CLEANING WIPES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 64 CHIN RESTRAINTS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 65 CHIN RESTRAINTS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 66 TUBE COVERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 67 TUBE COVERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 68 FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 69 FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 70 DC CONVERTORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 71 DC CONVERTORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 72 POWER & BATTERIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 73 POWER & BATTERIES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 74 HEADGEAR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 75 HEADGEAR MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 76 NEBULIZER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 77 NEBULIZER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 78 TUBING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)  
TABLE 79 TUBING MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 80 HUMIDIFIER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 81 HUMIDIFIER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 82 OTHER ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 83 GLOBAL ORAL APPLIANCE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)   
TABLE 84 GLOBAL ORAL APPLIANCE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)   
TABLE 85 MANDIBULAR ADVANCEMENT DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 86 MANDIBULAR ADVANCEMENT DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 87 TONGUE RETAINING DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 88 TONGUE RETAINING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)   
TABLE 89 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)  
TABLE 90 SLEEP APNEA DEVICES END-USERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)   
TABLE 91 NORTH AMERICA: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)   
TABLE 92 EUROPE: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)  
TABLE 93 ASIA: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)   
TABLE 94 ROW: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)   
TABLE 95 SLEEP APNEA DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($BILLION)   
TABLE 96 SLEEP APNEA DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($BILLION)   
TABLE 97 NORTH AMERICA: SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)  
TABLE 98 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)  
TABLE 99 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)  
TABLE 100 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)  
TABLE 101 EUROPE: SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 102 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 103 EUROPE: SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 104 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 105 ASIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 106 ASIA: SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 107 ASIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 108 ASIA: SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 109 ROW: SLEEP APNEA DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 110 ROW: SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 111 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)   
TABLE 112 ROW: SLEEP APNEA DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)   
TABLE 113 NEW PRODUCTS DEVELOPMENTS, 2009 - 2012  
TABLE 114 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ JOINT VENTURES, 2010 - 2012  
TABLE 115 MERGERS & ACQUISITIONS, 2009 - 2011  
TABLE 116 OTHERS, 2009 - 2012  
TABLE 117 CAREFUSION CORP.: NET REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 118 CAREFUSION CORP.: NET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 119 CAREFUSION CORP.: NET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 120 COMPUMEDICS LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 121 COMPUMEDICS LTD.: SLEEP MONITORING SEGMENT REVENUE, 2009 - 2011 ($MILLION)   
TABLE 122 COMPUMEDICS LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 123 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 124 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 125 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 126 GENERAL ELECTRIC CO.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)  
TABLE 127 GENERAL ELECTRIC CO.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 128 GENERAL ELECTRIC CO.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 129 INVACARE CORP.: NET SALES AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 130 INVACARE CORP.: NET SALES BY SEGMENTS, 2009 - 2011 ($MILLION)  
TABLE 131 INVACARE CORP.: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)  
TABLE 132 NATUS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 133 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 134 NIHON KOHDEN: NET SALES AND R&D EXPENSES, 2009 - 2011 ($MILLION)   
TABLE 135 NIHON KOHDEN: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)  
TABLE 136 NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)  
TABLE 137 ROYAL PHILIPS ELECTRONICS: NET SALES AND R&D EXPENSES, 2009 - 2011 ($MILLION)   
TABLE 138 ROYAL PHILIPS ELECTRONICS: NET SALES, 2009 - 2011 ($MILLION)  
TABLE 139 PHILIPS HEALTHCARE: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 140 ROYAL PHILIPS ELECTRONICS: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 141 RESMED, INC.: NET REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)   
TABLE 142 RESMED, INC.: NET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 143 RESMED, INC.: NET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
TABLE 144 SOMNOMEDICS GMBH: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2010 ($MILLION)   
TABLE 145 TELEFLEX, INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)   
TABLE 146 TELEFLEX, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)   
TABLE 147 TELEFLEX, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)   
   

LIST OF FIGURES   
   
FIGURE 1 SLEEP APNEA DEVICES MARKET, GEOGRAPHICAL RANKING, 2011  
FIGURE 2 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, 2011 & 2017 ($BILLION)  
FIGURE 3 TYPES OF SLEEP APNEA  
FIGURE 4 PORTER'S FIVE FORCES ANALYSIS  
FIGURE 5 THREAT OF NEW ENTRANTS  
FIGURE 6 SUPPLIER'S BARGAINING POWER  
FIGURE 7 BUYER'S BARGAINING POWER  
FIGURE 8 SEGMENT RIVALRY  
FIGURE 9 THREAT OF SUBSTITUTES  
FIGURE 10 GLOBAL SLEEP APNEA DEVICES MARKET SHARE, BY KEY PLAYERS, 2011  
FIGURE 11 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY KEY PLAYERS, 2011   
FIGURE 12 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY KEY PLAYERS, 2011   
FIGURE 13 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES, BY PRODUCTS  
FIGURE 14 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES, BY PRODUCTS  
FIGURE 15 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY END-USERS, 2011 & 2017  
FIGURE 16 KEY GROWTH STRATEGIES, MARCH 2009 - JUNE 2012  

Sleep apnea is a relatively new market in the medical field, gaining momentum at a fast pace, especially in developed geographies. The demand for sleep apnea devices is slated to increase at a faster pace, owing to gradually increasing awareness among both patients and the medical fraternity.

The penetration level of sleep apnea diagnosis, as well as therapy, is low across the globe, due to the lack of adequate awareness among both patients and physicians. Sleep apnea device manufacturers and hospitals, however, are actively engaged in educating primary care givers, sleep specialists, and patients about the disorder, informing them of available diagnostic and therapeutic options. Riding on these efforts, sleep apnea is now being recognized as a serious medical condition, which, if left untreated, can have fatal results.

The global sleep apnea devices market was valued at $7.96 billion in the year 2011 and is expected to reach $19.72 billion in the year 2017. North America was the largest sleep apnea diagnostic devices market, followed by Europe, and Asia. In the next few years, North America will continue to lead the sleep apnea device market, followed by Europe. The Asian region’s contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition.

The global sleep apnea devices market is broadly classified into two segments, namely, Diagnostic Devices, and Therapeutic devices. Incessantly rising obesity and incidence of sleep apnea, increasing awareness regarding hypertension, stroke, Type II diabetes/adult onset diabetes, and cardiovascular diseases and their association with sleep apnea, increased adoption and acceptance of home sleep testing devices, growing preference for oral appliances, technological advancement in diagnostic/therapeutic devices, and upcoming novel therapies are expected to drive the global sleep apnea diagnostic devices market in the next few years.

The global sleep apnea devices market is witnessing high competitive intensity. Segment rivalry is high, as there are a few well-established firms and several small firms with similar product offerings. The market is dominated by Philips Respironics and ResMed, Inc., which jointly comprise 70% of the market. Fisher and Paykel Healthcare, CareFusion Corporation, Natus Medical Incorporated, DeVilbiss Healthcare, Weinmann Medical Devices, etc. are a few of the other prominent players in the global sleep apnea devices market.

Global Sleep Apnea Devices Market Revenue, 2011 – 2017

Sleep Apnea Devices Market

Source: MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports